OptimizeRx (OPRX)
(Delayed Data from NSDQ)
$12.50 USD
-0.12 (-0.95%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $12.48 -0.02 (-0.16%) 7:58 PM ET
1-Strong Buy of 5 1
F Value A Growth D Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
OPRX 12.50 -0.12(-0.95%)
Will OPRX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for OPRX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for OPRX
Best Growth Stocks to Buy for August 1st
Bull Of The Day: OptimizeRX (OPRX)
OPRX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Does OptimizeRx Have a Moat in the Crowded HealthTech Space?
Blackbaud (BLKB) Q2 Earnings and Revenues Surpass Estimates
Take the Zacks Approach to Beat the Markets: AngloGold Ashanti, Caterpillar & Hershey in Focus
Other News for OPRX
Paynela Appoints Healthcare Technology Veteran William Febbo to Board of Directors | OPRX Stock News
OptimizeRx Corp (OPRX) Stock Price Down 3.9% on Jul 18
OptimizeRx: Stock Could Rise As Profitability Is Achieved
OptimizeRx Sets Second Quarter 2025 Conference Call for August 7, 2025, at 4:30 p.m. ...
OptimizeRx Corp (OPRX) Trading 8.48% Higher on Jul 16